CTLA4 and neoplasm: Mice received intraperitoneal (i.p.)injections of 0.5 mg clodronate every 3 days, starting from the day of tumor injection (day 0), in addition to CTLA-4 blockade monotherapy or combination therapy of IVAX and CTLA-4 blockade (Fig. 1 A).